Evaluation and Comparison of HbA1C Level in Diabetic Patients with and without Foot Ulcer: A Case control Study
Iranian Journal of Emergency Medicine,
Vol. 11 No. 1 (2024),
1 January 2024
,
Page e1
https://doi.org/10.22037/ijem.v11i1.40730
Abstract
Introduction: Diabetic foot is one of the long-term microvascular complications of diabetes mellitus (DM). The prevention of foot ulcers is the most effective way to reduce severe morbidity and mortality in patients with diabetes. Appropriate glycemic control is one of the most important preventive measures for diabetic foot ulcers. Glycosylated hemoglobin (HbA1C) is representative of long-term blood glucose levels over the prior three months. The present study evaluated the relationship between HbA1C levels and the development of diabetic foot ulcers.
Methods: The present study was an analytical case-control study conducted in Ali-ibn-Abitaleb Hospital in Zahedan, Iran, in 2022. 130 patients comprising 65 DM patients with diabetic foot ulcers and 65 DM patients without foot ulcers were included in this study. Demographic and laboratory information was collected by the researcher using a checklist. The data were analyzed using SPSS software.
Results: The average age of the control and case groups was 64.1 and 62.6 years, respectively. The results showed a significant relationship between the age of 60-70 years and the onset of diabetic foot ulcers. There was also a significant relationship between the female gender and the occurrence of diabetic foot. No significant relationship was observed between the duration of DM and the onset of diabetic foot. The results showed that 87.7% of the people in the control group had no previous history of diabetic foot. However, 76.9% of the people in the case group had a prior history of diabetic foot. There was a significant relationship between the previous history of the diabetic foot and its recurrence in diabetic patients. Regarding the serum level of HbA1C, 78.5% and 12.3% of patients in the case group had moderate (7-10%) and poor control (10-13%), respectively. 43.1%, 50.7%, and 6.2% of people in the control group had good, moderate, and poor control and in the multivariable model, only the previous history remained in the model, which showed that the probability of infection in people with a previous history is almost 24 times higher than in people without a previous history.
Conclusion: The results indicate that age, female gender, history of diabetic foot, and high serum level of HbA1c had a significant relationship with diabetic foot. Since the serum level of HbA1c is an important indicator of long-term blood sugar control, it can possibly be used as a reliable factor to predict diabetic foot complications.
- Diabetes mellitus
- Diabetic foot
- Foot ulcer
- Glycated hemoglobin
How to Cite
References
Committee ADAPP, Committee: ADAPP. 16. Diabetes care in the hospital: Standards of Medical Care in Diabetes—2022. Diabetes care. 2022;45(Supplement_1):S244-S53.
Organization WH. www. who. int/news-room/fact-sheets/detail/the-top-10-causes-of-death.
Jafarvand E, Ataey A, Edalati S. Epidemiology and death trends due to diabetes in Iran. Internal Medicine Today. 2021;27(2):198-213.
Heitzman J. Foot care for patients with diabetes. Topics in geriatric rehabilitation. 2010;26(3):250-63.
FARZANEGI P, SHOKRIAN F. INTERACTIVE EFFECT OF AEROBIC TRAINING WITH PORTULACA OLERACEA SEEDS ON LEVELS OF MMP-1, MMP-3 AND MIP-1? IN WOMEN WITH TYPE II DIABETES. 2015.
Brognara L, Volta I, Cassano VM, Navarro-Flores E, Cauli O. The association between cognitive impairment and diabetic foot care: Role of neuropathy and glycated hemoglobin. Pathophysiology. 2020;27(1):14-27.
Sherwani SI, Khan HA, Ekhzaimy A, Masood A, Sakharkar MK. Significance of HbA1c test in diagnosis and prognosis of diabetic patients. Biomarker insights. 2016;11:BMI. S38440.
Bakri FG, Allan AH, Khader YS, Younes NA, Ajlouni KM. Prevalence of diabetic foot ulcer and its associated risk factors among diabetic patients in Jordan. J Med J. 2012;46(2):118-25.
Banik PC, Barua L, Moniruzzaman M, Mondal R, Zaman F, Ali L. Risk of diabetic foot ulcer and its associated factors among Bangladeshi subjects: a multicentric cross-sectional study. BMJ Open. 2020;10(2):e034058.
Wu SC, Driver VR, Wrobel JS, Armstrong DG. Foot ulcers in the diabetic patient, prevention and treatment. Vasc Health Risk Manag. 2007;3(1):65-76.
Eyth E, Naik R. Hemoglobin A1c. 2019.
Casadei G, Filippini M, Brognara L. Glycated hemoglobin (HbA1c) as a biomarker for diabetic foot peripheral neuropathy. Diseases. 2021;9(1):16.
Van Netten J, Price PE, Lavery L, Monteiro‐Soares M, Rasmussen A, Jubiz Y, et al. Prevention of foot ulcers in the at‐risk patient with diabetes: a systematic review. Diabetes/metabolism research and reviews. 2016;32:84-98.
Meidani M, Khorvash F, Rajabpournikfam MR. The Relationship between Controlling HbA1C and Infectious Foot Ulcer. Journal of Isfahan Medical School. 2012;30(175).
Mehraj M, Shah I. A review of Wagner classification and current concepts in management of diabetic foot. Int J Orthop Sci. 2018;4(1):933-5.
Armstrong DG, Holtz-Neiderer K, Wendel C, Mohler MJ, Kimbriel HR, Lavery LA. Skin temperature monitoring reduces the risk for diabetic foot ulceration in high-risk patients. The American journal of medicine. 2007;120(12):1042-6.
Paras M, Hameed EAB. The risk factors of developing diabetic foot ulcers incidence with diabetic patients in Mukalla/Yemen. Sudan Journal of Medical Sciences (SJMS). 2020:153–62-–62.
Almobarak AO, Awadalla H, Osman M, Ahmed MH. Prevalence of diabetic foot ulceration and associated risk factors: an old and still major public health problem in Khartoum, Sudan? Ann Transl Med. 2017;5(17):340.
Lazzarini PA, O’Rourke SR, Russell AW, Derhy PH, Kamp MC, d’Emden MC, et al. Queensland’s high risk foot database: tracking the length and width of Queensland’s foot ulcers. Journal of Foot and Ankle Research. 2013;6(1):O21.
Apelqvist J, Agardh C-D. The association between clinical risk factors and outcome of diabetic foot ulcers. Diabetes research and clinical practice. 1992;18(1):43-53.
Ramani A, Nayak S, Gopalakrishna K, Kundaje G. Glycemic control and its relationship to diabetic foot ulcers. Indian Journal of Pathology & Microbiology. 1991;34(3):161-5.
Din N, Khan M, Khan BD, Ghaffar T, Ikram MT, Salman MA, et al. Association of Severity of Diabetic Foot Ulcer with Glycated Hemoglobin A1C Levels: Diabetic Foot Ulcer with Glycated HBA1C Levels. Pakistan Journal of Health Sciences. 2023:161-5.
Moodley RM, D'Almeida SS, Lameko V, Ghimire S. Novel Relationship Between Hemoglobin A1c Levels and Foot Ulcer Development Among Patients With Type 2 Diabetes Mellitus Admitted at Tupua Tamasese Meaole Hospital. Cureus. 2021;13(11).
Ghanbari A, Nouri M, Darvishi M. Evaluation of Relationship between Serum Hemoglobin A1C Level and Severity of Diabetic Foot Ulcers Based on Wagner Criteria. Journal of Medicinal and Chemical Sciences. 2023;6(9):2234-41.
- Abstract Viewed: 191 times
- pdf Downloaded: 246 times
